BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1174 related articles for article (PubMed ID: 19212411)

  • 1. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
    Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
    Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of sarcosine metabolism in prostate cancer progression.
    Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
    Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
    Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
    Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
    Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
    PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].
    Darbon JM
    Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
    Khan AP; Poisson LM; Bhat VB; Fermin D; Zhao R; Kalyana-Sundaram S; Michailidis G; Nesvizhskii AI; Omenn GS; Chinnaiyan AM; Sreekumar A
    Mol Cell Proteomics; 2010 Feb; 9(2):298-312. PubMed ID: 19955085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of
    Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
    J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcosine as a potential prostate cancer biomarker--a review.
    Cernei N; Heger Z; Gumulec J; Zitka O; Masarik M; Babula P; Eckschlager T; Stiborova M; Kizek R; Adam V
    Int J Mol Sci; 2013 Jul; 14(7):13893-908. PubMed ID: 23880848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic signatures of aggressive prostate cancer.
    McDunn JE; Li Z; Adam KP; Neri BP; Wolfert RL; Milburn MV; Lotan Y; Wheeler TM
    Prostate; 2013 Oct; 73(14):1547-60. PubMed ID: 23824564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
    Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
    Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMEFF2 and SARDH cooperate to modulate one-carbon metabolism and invasion of prostate cancer cells.
    Green T; Chen X; Ryan S; Asch AS; Ruiz-Echevarría MJ
    Prostate; 2013 Oct; 73(14):1561-75. PubMed ID: 23824605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics research on potential role for 9-cis-retinoic acid in breast cancer progression.
    Wu J; Yang R; Zhang L; Li Y; Liu B; Kang H; Fan Z; Tian Y; Liu S; Li T
    Cancer Sci; 2018 Jul; 109(7):2315-2326. PubMed ID: 29737597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression.
    Jentzmik F; Stephan C; Lein M; Miller K; Kamlage B; Bethan B; Kristiansen G; Jung K
    J Urol; 2011 Feb; 185(2):706-11. PubMed ID: 21168877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
    de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
    Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in localized prostate cancer.
    Ferro M; Buonerba C; Terracciano D; Lucarelli G; Cosimato V; Bottero D; Deliu VM; Ditonno P; Perdonà S; Autorino R; Coman I; De Placido S; Di Lorenzo G; De Cobelli O
    Future Oncol; 2016 Feb; 12(3):399-411. PubMed ID: 26768791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
    Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
    PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor activity of the transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2) correlates with its ability to modulate sarcosine levels.
    Chen X; Overcash R; Green T; Hoffman D; Asch AS; Ruiz-Echevarría MJ
    J Biol Chem; 2011 May; 286(18):16091-100. PubMed ID: 21393249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.
    Cha YJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(11):7824-33. PubMed ID: 25550822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.